Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 106

    1.

    General practitioners and pharmaceutical sales representatives: quality improvement research.

    Spurling G, Mansfield P.

    Qual Saf Health Care. 2007 Aug;16(4):266-70.PMID: 17693673 [PubMed - indexed for MEDLINE]Related articles

    2.

    Impact of pharmaceutical promotion on prescribing decisions of general practitioners in Eastern Turkey.

    Vancelik S, Beyhun NE, Acemoglu H, Calikoglu O.

    BMC Public Health. 2007 Jun 25;7:122.PMID: 17592644 [PubMed - indexed for MEDLINE]Related articlesFree article

    3.

    Value of services provided by pharmaceutical companies: perceptions of physicians and pharmaceutical sales representatives.

    Gaedeke RM, Tootelian DH, Sanders EE.

    Health Mark Q. 1999;17(1):23-31.PMID: 11066720 [PubMed - indexed for MEDLINE]Related articles

    4.

    National survey of recent changes in hospital policies on pharmaceutical sales representatives' activities.

    Thomas J 3rd.

    Am J Hosp Pharm. 1989 Mar;46(3):565-9.PMID: 2719042 [PubMed - indexed for MEDLINE]Related articles

    5.

    Promotional methods used by representatives of drug companies: a prospective survey in general practice.

    Schramm J, Andersen M, Vach K, Kragstrup J, Kampmann JP, Søndergaard J.

    Scand J Prim Health Care. 2007 Jun;25(2):93-7.PMID: 17497486 [PubMed - indexed for MEDLINE]Related articles

    6.

    Characteristics of physicians who frequently see pharmaceutical sales representatives.

    Alkhateeb FM, Khanfar NM, Clauson KA.

    J Hosp Mark Public Relations. 2009 Jan-Jun;19(1):2-14.PMID: 19197653 [PubMed - indexed for MEDLINE]Related articles

    7.

    Factors affecting feasibility and acceptability of a practice-based educational intervention to support evidence-based prescribing: a qualitative study.

    Watkins C, Timm A, Gooberman-Hill R, Harvey I, Haines A, Donovan J.

    Fam Pract. 2004 Dec;21(6):661-9. Epub 2004 Nov 4.PMID: 15528289 [PubMed - indexed for MEDLINE]Related articlesFree article

    8.

    Differences in prescribing between GPs: impact of the cooperation with pharmacists and impact of visits from pharmaceutical industry representatives.

    Muijrers PE, Grol RP, Sijbrandij J, Janknegt R, Knottnerus JA.

    Fam Pract. 2005 Dec;22(6):624-30. Epub 2005 Jul 29.PMID: 16055474 [PubMed - indexed for MEDLINE]Related articlesFree article

    9.

    Is your sample cupboard relevant to your practice?

    Spurling G, Kyle G.

    Aust Fam Physician. 2007 Mar;36(3):187-8, 192.PMID: 17339989 [PubMed - indexed for MEDLINE]Related articlesFree article

    10.

    Structured approach to pharmaceutical representatives. Family medicine residency program.

    Kelcher S, Brownoff R, Meadows LM.

    Can Fam Physician. 1998 May;44:1053-6, 1059-60.PMID: 9612591 [PubMed - indexed for MEDLINE]Related articlesFree article

    11.

    Patient awareness and concern regarding pharmaceutical manufacturer interactions with doctors.

    Edwards D, Ballantyne A.

    Intern Med J. 2009 Mar;39(3):191-6.PMID: 19383067 [PubMed - indexed for MEDLINE]Related articles

    12.

    Perceptions of the influence of prescription medicine samples on prescribing by family physicians.

    Hall KB, Tett SE, Nissen LM.

    Med Care. 2006 Apr;44(4):383-7.PMID: 16565641 [PubMed - indexed for MEDLINE]Related articles

    13.

    Relationships of physicians with pharmaceutical sales representatives and pharmaceutical companies: an exploratory study.

    Anadaleeb SS, Tallman RF.

    Health Mark Q. 1996;13(4):79-89.PMID: 10159647 [PubMed - indexed for MEDLINE]Related articles

    14.

    Determinants of the range of drugs prescribed in general practice: a cross-sectional analysis.

    de Bakker DH, Coffie DS, Heerdink ER, van Dijk L, Groenewegen PP.

    BMC Health Serv Res. 2007 Aug 22;7:132.PMID: 17711593 [PubMed - indexed for MEDLINE]Related articlesFree article

    15.

    Improving the repeat prescribing process in a busy general practice. A study using continuous quality improvement methodology.

    Cox S, Wilcock P, Young J.

    Qual Health Care. 1999 Jun;8(2):119-25.PMID: 10557675 [PubMed - indexed for MEDLINE]Related articlesFree article

    16.

    Encounters with pharmaceutical sales representatives among practicing internists.

    Ferguson RP, Rhim E, Belizaire W, Egede L, Carter K, Lansdale T.

    Am J Med. 1999 Aug;107(2):149-52.PMID: 10460046 [PubMed - indexed for MEDLINE]Related articles

    17.

    Improving medication safety: influence of a patient-specific prescriber feedback program on rate of medication reviews performed by Australian general medical practitioners.

    Roughead E, Pratt N, Peck R, Gilbert A.

    Pharmacoepidemiol Drug Saf. 2007 Jul;16(7):797-803.PMID: 17476702 [PubMed - indexed for MEDLINE]Related articles

    18.

    GP recruitment and retention: a qualitative analysis of doctors' comments about training for and working in general practice.

    Evans J, Lambert T, Goldacre M.

    Occas Pap R Coll Gen Pract. 2002 Feb;(83):iii-vi, 1-33.PMID: 12049026 [PubMed - indexed for MEDLINE]Related articlesFree article

    19.

    Primary Care Research Team Assessment (PCRTA): development and evaluation.

    Carter YH, Shaw S, Macfarlane F.

    Occas Pap R Coll Gen Pract. 2002 Feb;(81):iii-vi, 1-72.PMID: 12049028 [PubMed - indexed for MEDLINE]Related articlesFree article

    20.

    An inclusive approach to raising standards in general practice: working with a 'community of practice' in Western Australia.

    Jiwa M, Deas K, Ross J, Shaw T, Wilcox H, Spilsbury K.

    BMC Med Res Methodol. 2009 Feb 28;9:13.PMID: 19250548 [PubMed - indexed for MEDLINE]Related articlesFree article

    Supplemental Content

    Find related data